Stock listing

BOATS:MIRA MIRA Pharmaceuticals, Inc. Stock

US listing (BOATS) of MIRA Pharmaceuticals, Inc. · home listing NASDAQ:MIRA

Follow MIRA Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:MIRA

$0.62 USD -0.01 (-1.5%)

Close on Oct 23, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MIRA

Past 3 months -35.1% · daily closes, Jul 6, 2026 – Oct 23, 2026, adjusted for splits
Day range
$0.60 – $0.66 USDOct 23, 2026
Volume
106,101 sharesOct 23, 2026
Market cap
$26.05M USDAt the close on Oct 23, 2026 · price × 42.04M shares outstanding
MIRA Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MIRA · Home$0.62 USD-0.009 (-1.5%)106,101$0.63$0.66$0.60$0.629Close on Oct 23, 2026
Frankfurt:K6S€0.553 EUR-0.051 (-8.5%)—€0.543€0.553€0.543€0.604Close on Oct 23, 2026

Daily closes

Last 3 months, Jul 23, 2026 – Oct 23, 2026 · NASDAQ:MIRA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.62-0.009-1.5%$0.63$0.66$0.60106,101
$0.629-0.053-7.8%$0.73$0.73$0.622100,247
$0.682+0.032+4.9%$0.665$0.693$0.665127,965
$0.65+0.008+1.2%$0.645$0.661$0.64510,462
$0.642+0.01+1.5%$0.626$0.647$0.62466,029
$0.632-0.026-3.9%$0.68$0.68$0.631123,143
$0.658-0.024-3.5%$0.635$0.679$0.626128,627
$0.682+0.016+2.4%$0.667$0.686$0.6675,763
$0.666-0.039-5.5%$0.699$0.699$0.6667,694
$0.705-0.04-5.4%$0.759$0.759$0.68589,517
$0.746+0.043+6.0%$0.72$0.75$0.70352,431
$0.703-0.007-1.0%$0.71$0.71$0.681142,664
$0.71-0.002-0.3%$0.722$0.741$0.70367,731
$0.712-0.024-3.3%$0.759$0.76$0.70105,700
$0.736+0.006+0.8%$0.73$0.75$0.71186,400
$0.73+0.007+1.0%$0.73$0.758$0.711158,000
$0.723-0.122-14.4%$0.84$0.85$0.62667,700
$0.845-0.027-3.1%$0.859$0.869$0.8272,100
$0.872-0.031-3.4%$0.87$0.90$0.86561,400
$0.903+0.003+0.3%$0.898$0.911$0.87565,800
$0.90+0.06+7.1%$0.86$0.90$0.8594,700
$0.84-0.018-2.1%$0.858$0.86$0.83154,100
$0.858-0.048-5.3%$0.936$0.94$0.85118,600
$0.906+0.027+3.1%$0.865$0.919$0.847127,800
$0.879+0.047+5.6%$0.821$0.90$0.798387,600
$0.832+0.073+9.6%$0.789$0.832$0.77682,600
$0.759+0.039+5.4%$0.73$0.76$0.722131,400
$0.72+0.006+0.8%$0.72$0.737$0.7176,500
$0.714-0.039-5.2%$0.753$0.754$0.71471,500
$0.753-0.021-2.7%$0.766$0.78$0.728171,500
$0.774-0.015-1.9%$0.789$0.82$0.774105,500
$0.789+0.008+1.0%$0.79$0.83$0.759138,400
$0.781+0.005+0.6%$0.771$0.794$0.75653,200
$0.776+0.012+1.6%$0.76$0.81$0.751177,200
$0.764+0.024+3.2%$0.735$0.85$0.735338,500
$0.74-0.11-12.9%$0.83$0.84$0.731490,500
$0.85-0.01-1.2%$0.857$0.935$0.825575,000
$0.86+0.09+11.7%$0.74$1.10$0.72129,281,100
$0.77+0.02+2.7%$0.75$0.782$0.7544,300
$0.75-0.02-2.6%$0.75$0.779$0.7531,800
$0.77+0.02+2.7%$0.75$0.778$0.7444,100
$0.75-0.025-3.2%$0.77$0.774$0.7527,300
$0.775-0.013-1.6%$0.80$0.81$0.76834,700
$0.788+0.024+3.1%$0.779$0.825$0.7765,100
$0.764+0.054+7.6%$0.72$0.82$0.72117,400
$0.71-0.06-7.8%$0.77$0.796$0.7141,700
$0.77+0.005+0.7%$0.76$0.80$0.7641,100
$0.765-0.025-3.2%$0.765$0.795$0.7640,300
$0.79+0.01+1.3%$0.80$0.81$0.77460,000
$0.78+0.03+4.0%$0.782$0.811$0.76675,500
$0.75+0.011+1.5%$0.77$0.825$0.7583,800
$0.739-0.039-5.0%$0.773$0.785$0.73826,400
$0.778+0.01+1.4%$0.803$0.803$0.77118,568
$0.767+0.027+3.7%$0.759$0.79$0.741114,143
$0.74+0.062+9.1%$0.68$0.75$0.67156,300
$0.678+0.02+3.0%$0.698$0.698$0.65971,400
$0.658-0.017-2.5%$0.676$0.69$0.63869,900
$0.675+0.061+9.9%$0.654$0.73$0.65352,300
$0.614-0.178-22.5%$0.778$0.85$0.60424,200
$0.792-0.024-2.9%$0.835$0.835$0.77287,500
$0.816-0.026-3.1%$0.851$0.897$0.8068,600
$0.842+0.002+0.2%$0.86$0.865$0.83149,500
$0.84-0.042-4.8%$0.88$0.92$0.83137,700
$0.8820.000.0%$0.88$0.95$0.8726,300
$0.882-0.046-5.0%$0.95$0.95$0.8389,300
$0.9280.000.0%$0.90$0.95$0.88588,100
Ticker
BOATS:MIRA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Latest news

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review

Sep 17, 2026

Closed $0.759 (+5.4%) on Sep 17, 2026

MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND

Sep 1, 2026

Closed $0.86 (+11.7%) on Sep 1, 2026

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Aug 6, 2026

Closed $0.678 (+3.0%) on Aug 6, 2026

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

Jul 30, 2026

Closed $0.816 (-3.1%) on Jul 30, 2026

MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain

Jul 10, 2026

Closed $0.925 (+0.5%) on Jul 10, 2026

MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction

Jul 6, 2026

MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC

Jun 25, 2026

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

Jun 17, 2026

MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1

Jun 4, 2026

MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN

May 27, 2026

All MIRA Pharmaceuticals, Inc. news

Decks

MIRA Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
17 in the last 12 months · 76 in all · newest Sep 17, 2026 · oldest 2023
Decks
2 decks · latest October 2026

Where MIRA Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MIRA · Home listingNASDAQUnited StatesUSD
gettex:K6SgettexGermanyEUR
Lang & Schwarz:A3EQWLLang & SchwarzGermanyEUR
LS Exchange:A3EQWLLS ExchangeGermanyEUR
BOATS:MIRA · This pageBOATSUnited StatesUSD
Tradegate:K6STradegateGermanyEUR
Dusseldorf:K6SDusseldorfGermanyEUR
Frankfurt:K6SFrankfurtGermanyEUR
Hamburg:K6SHamburgGermanyEUR
Munich:K6SMunichGermanyEUR
Stuttgart:K6SStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about MIRA Pharmaceuticals, Inc.